Halank M, Marx C, Baretton G, Müller K-M, Ehninger G, Höffken G
Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Deutschland.
Onkologie. 2004 Oct;27(5):472-4. doi: 10.1159/000080368.
Chronic myeloproliferative disorders (CMPD) seem to be associated with an increased risk for pulmonary hypertension (PH).
A patient with history of chronic idiopathic myelofibrosis (CIMF) presented with progressive dyspnea (New York Heart Association class III). Until this time he had not received specific treatment for CIMF. Echocardiography and rightheart catheterization confirmed PH. Further diagnostic procedures excluded a specific cause of PH. Therefore, primary PH was assumed. 2 years later he presented again with progressive dyspnea due to a progress of PH. A few days later the patient died from acute posterior myocardial infarction. Pathologic examination of the lung showed an obstruction of the small vessels by conglomerates of megakaryocytes.
We conclude that PH developed secondarily due to CMPD. PH should be suspected in patients with CMPD and should influence the decision for treatment of CMPD.
慢性骨髓增殖性疾病(CMPD)似乎与肺动脉高压(PH)风险增加有关。
一名有慢性特发性骨髓纤维化(CIMF)病史的患者出现进行性呼吸困难(纽约心脏协会III级)。在此之前,他尚未接受过针对CIMF的特异性治疗。超声心动图和右心导管检查证实存在PH。进一步的诊断程序排除了PH的特定病因。因此,假定为原发性PH。2年后,由于PH进展,他再次出现进行性呼吸困难。几天后,患者死于急性后壁心肌梗死。肺部病理检查显示小血管被巨核细胞团块阻塞。
我们得出结论,PH是由CMPD继发产生的。CMPD患者应怀疑存在PH,并且这应影响CMPD的治疗决策。